Called "immunotherapy," the treatment helps a person's immune system fight off cancer cells in a way that is similar to fighting a virus.
In this new therapy, doctors take white blood cells called t-cells from cancer patients and genetically modify them.
The cells are then put back in the patient to multiply.
Researchers said the genetically-modified cells could protect the patient from cancerous invasions.
One study shows the therapy eliminated all symptoms in 94 percent of participants with acute lymphoblastic leukemia, with other blood cancers showing response rates of greater than 80 percent.
-Mornings @ ANC, February 17, 2016
source: www.abs-cbnnews.com
